HIV-1 gp41 by N-domain binds the potential receptor protein P45

International Archives of Allergy and Immunology

Volumn 121, Issue 3, 2000, Pages 253-257

  Xiao, Yi ^a   Wu, Weicheng ^a   Dierich, Manfred P ^b   Chen, Ying Hua ^a  

^a TSINGHUA UNIVERSITY   (China)

^b UNIVERSITY OF INNSBRUCK   (Austria)

Author keywords

Binding site; HIV 1 gp41; N domain; Potential receptor protein

Indexed keywords

GLYCOPROTEIN GP 41; RECEPTOR PROTEIN; RECOMBINANT PROTEIN; VIRUS GLYCOPROTEIN;

AMINO TERMINAL SEQUENCE; ARTICLE; BINDING SITE; CAPILLARY ELECTROPHORESIS; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; CRYSTAL STRUCTURE; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MEMBRANE FUSION; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; SURFACE PLASMON RESONANCE; VIRUS INFECTIVITY;

EID: 0034015712     PISSN: 10182438     EISSN: None     Source Type: Journal    
DOI: 10.1159/000024325     Document Type: Article

References (23)

1. Dalgleish AG, Beverley PCL, Clapham PR, Crawford DH, Greaves MF, Weiss RA: The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus. Nature 1984;312:763-767.
2. Feng V, Broder CC, Kennedy PE, Berger EA: HIV-1 entry cofactor: Functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science 1996;272:872-877.
3. Dragic T, Litwin V, Allaway GP, Martin SR, Huang Y, Nagashima KA, Cayanan C, Maddon PJ, Koup RA, Moore JP, Paxton WA: HIV-1 entry into CD4+cells is mediated by the chemokine receptor CC-CKR-5. Nature 1996;381:667-673.
4. Binley J, Moore JP: HIV cell fusion: The viral mousetrap. Nature 1997;387:346-348.
5. Chen YH, Ebenbichler C, Vornhagen R, Schulz TF, Steindl F, Bock G, Katinger H, Dierich MP: HIV-1 gp41 contains two sites for interaction with several proteins on the helper T-lymphoid cell line, H9. AIDS 1992;6:533-539.
6. Chen YH, Christiansen A, Bock G, Dierich MP: HIV-2 transmembrane protein gp.36 like HIV-1 gp41 binds to human lymphocytes and monocytes. AIDS 1995;9:1193-1194.
7. Henderson LA, Qureshi MN: A peptidc inhibitor of human immunodeficiency virus infection binds to novel human cell surface polypeptides .J Biol Chem 1993;268:15291-15297.
8. Ebenbiehler C, Ruder C, Vornhagen R, Ratner L, Dierich MP: Cell surface proteins binding to recombinant soluble HIV-I and HIV-2 trans-membrane proteins: AIDS 1993;7:489-495.
9. Weissenhorn W, Dessen A, Harrison SC. Skehel JJ. Wilev DC: Atomic structure of the ectodomain from HIV-1 gp41. Nature 1997;387:426-430.
10. Chan DC, Pass D, Berger JM, Kim PS: Core structure of gp41 from the HIC envelope glycoprotein. Cell 1997;89:263-273.
11. Chen YH, Bock G, Vornhagen R, Steindl F, Katinger H, Dierich MP: HIV-2 gp41 binding to human peripheral blood mononuclear cells occurs preferentially to B lymphocytes and monocytes. Immunobiology 1993;188:323-329.
12. Chen YH, Dierich MP: Identification of a second site in HIV-1 gp41 mediating binding to cells, Immunol Lett 1996;52:153-156.
13. Chen YH, Bock G, Vornhagen R, Steindl F, Katinger H, Dierich MP: HIV-1 gp41 binding proteins and antibodies to gp41 could inhibit enhancement of human Raji cell MHC class I and II antigen expression by gp41. Mol Immunol 1994;31:977-982.
14. Chen YH, Xiao Y, Wu W, Yang J, Sui SF, Dierich MP: HIV-1 gp41 by the C-domain hinds the putative cellular receptor protein P62. AIDS, in press.
15. Vornhagen R, Hinderer W, Nebel-Schickel H, Horn J, Pichler W, Franke M, Wolf H, Sonneborn HH: Development of efficient HIV-specific test systems using recombinant viral antigens. Biotest Bull 1990;4:91-96.
16. Chen YH,. Buck G, Vornhagen R, Steindl F, Katinger H, Dierich MP: HIV-1 gp41 hinds to several proteins on the human B cell line, Raji. Mol Immunol 1993;30:1159-1163.
17. Dubs MC, Altschuh D, Van Regenmortel MHV: Interaction between viruses and monoclonal antibodies studied by surface plasmon resonance, Immunol Lett 1991;31:59-64.
18. Liu Z, Qin H, Xiao C, Wen C, Wang S, Sui SF: Specific binding of avidin to biotin containing lipid lamella surfaces studied with monolayers and liposomes. Eur Biophys J 1995;24:31-38.
19. Caffrey M, Cai ML, Kaufman J, Stahl SJ; Wingfield FT, Covell DG, Grorenborn AM. Clore GM: Three-dimensional solution structure of the 44 kDa ectodomain of SIV gp41. EMBO J 1998;17:4572-4584.
20. Jiang S, Lin K, Strick N: HIV-1 inhibition by a peptide. Nature 1993;365:113.
21. Neurath AR, Lin K, Strick N, Jiang S: Two partially overlapping antiviral peptides from the external portion of HIV type 1 glycoprotein 41. adjoining the transmembrane region, affect the glycoprotein 41 fusion domain. AIDS Res Human Retroviruses. 1995;11:189-190.
22. Furuta RA, Wild CT, Weng Y, Weiss CD: Capture of an early fusion-active conformation of HIV-1 gp41. Nat Struct Biol 1998;5:276-279.
23. Chan DC, Kim PS: HIV entry and its inhibition. Cell 1998;93:681-684.